BIOMAT Database Logo BIOMAT Database Logo

In vitro effects of 3'-azido-3'-deoxythymidine (AZT) on normal human polymorphonuclear cell and monocyte-macrophage functional capacities. 1996

C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
University of L'Aquila degli Abruzzi, Medical School, Italy.

The in vitro effects of 3'-azido-3'-deoxythymidine (AZT) (at concentrations of 1, 10 and 100 microM, respectively) on normal human polymorphonuclear cell (PMN) and monocyte-macrophage functional capacities were evaluated. Results show that AZT was able to decrease monocyte phagocytosis only, while PMN polarization, phagocytosis and killing were unaffected by drug pretreatment. Quite interestingly, monocyte-derived macrophages maintained their unaltered phagocytic function in spite of the presence of AZT in overnight cultures, thus indicating that monocytes are more susceptible than macrophages to the antiproliferative effects of AZT. Since our data indicate that AZT affects normal human monocyte phagocytosis, it is advisable to evaluate this immune parameter in HIV+ patients administered with this drug.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
January 1994, Experimental hematology,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
Structure of 3'-azido-3'-deoxythymidine, AZT.
April 1988, Acta crystallographica. Section C, Crystal structure communications,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
3'-azido-3'-deoxythymidine (AZT) transplacental perfusion kinetics and DNA incorporation in normal human placentas perfused with AZT.
July 1999, Mutation research,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
3'-Azido-3'-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells.
July 1988, British journal of haematology,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
Effects of 3'-azido-3'-deoxythymidine (AZT) on short-term cultured human peripheral blood lymphocytes.
April 1989, European journal of clinical investigation,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
January 1989, Experimental hematology,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
Metabolism of 3'-azido-3'-deoxythymidine (AZT) in human placental trophoblasts and Hofbauer cells.
July 1994, Biochemical pharmacology,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
Intracellular activity of zidovudine (3'-azido-3'-deoxythymidine, AZT) against Salmonella typhimurium in the macrophage cell line J774-2.
May 1992, Antimicrobial agents and chemotherapy,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
In vivo toxicity of 3'-azido-3'-deoxythymidine (AZT) on CBA/Ca mice.
September 1990, International journal of cell cloning,
C De Simone, and A B Maffione, and R Calvello, and C Nacci, and G Sciannameo, and B Greco, and L Caradonna, and S Pece, and S Antonaci, and E Jirillo
Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
January 1989, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!